par Oakman, Catherine;Moretti, E;Sotiriou, Christos ;Viale, G;Di Leo, Angelo
Référence Journal of the National Cancer Institute, 101, 24, page (1735-6; author reply 1736-7)
Publication Publié, 2009-12
Référence Journal of the National Cancer Institute, 101, 24, page (1735-6; author reply 1736-7)
Publication Publié, 2009-12
Article révisé par les pairs
Titre: |
|
Auteur: | Oakman, Catherine; Moretti, E; Sotiriou, Christos; Viale, G; Di Leo, Angelo |
Informations sur la publication: | Journal of the National Cancer Institute, 101, 24, page (1735-6; author reply 1736-7) |
Statut de publication: | Publié, 2009-12 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Anthracyclines -- administration & dosage |
Antigens, Neoplasm -- genetics | |
Antigens, Neoplasm -- metabolism | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- enzymology | |
Breast Neoplasms -- metabolism | |
Chemotherapy, Adjuvant | |
DNA Topoisomerases, Type II, Eukaryotic -- genetics | |
DNA Topoisomerases, Type II, Eukaryotic -- metabolism | |
DNA-Binding Proteins -- genetics | |
DNA-Binding Proteins -- metabolism | |
Female | |
Gene Deletion | |
Gene Expression Regulation, Neoplastic | |
Humans | |
In Situ Hybridization, Fluorescence | |
Predictive Value of Tests | |
Receptor, erbB-2 -- metabolism | |
Up-Regulation | |
Note générale: | Comment |
Letter | |
Langue: | Anglais |
Identificateurs: | urn:issn:0027-8874 |
info:doi/10.1093/jnci/djp402 | |
info:pii/djp402 | |
info:scp/72649099933 | |
info:pmid/19893008 |